Skip to main content

Table 3 The incidence rate ratio of using licit prescription drugs and costs for licit prescription drug use among patients

From: Licit prescription drug use in a Swedish population according to age, gender and socioeconomic status after adjusting for level of multi-morbidity

Variables

 

DDDs

Costs

  

IRR (95%)

P-value

IRR (95%)

P-value

Gender1

     
 

Female

1

 

1

 
 

Male

0.97 (0.96–0.98)

0.000

1.14 (1.13–1.15)

0.000

Age (years)2

     
 

20–29

1

 

1

 
 

30–39

1.07 (1.05–1.09)

0.000

1.07 (1.05–1.10)

0.000

 

40–49

1.50 (1.47–1.53)

0.000

1.42 (1.39–1.46)

0.000

 

50–59

2.18 (2.14–2.22)

0.000

1.63 (1.59–1.67)

0.000

 

60–69

2.97 (2.91–3.03)

0.000

1.88 (1.84–1.92)

0.000

 

70–79

3.68 (3.60–3.76)

0.000

1.95 (1.90–1.99)

0.000

 

80

4.50 (4.40–4.60)

0.000

1.95 (1.91–2.00)

0.000

Educational level3

up to 60–69 years

1

1

 

1

 
 

2

0.99 (0.96–1.02)*

0.341

1.05 (1.02–1.09)

0.002

 

3

0.85 (0.83–0.87)

0.000

0.96 (0.93–0.98)

0.002

 

4

0.78 (0.76–0.80)

0.000

0.92 (0.89–0.94)

0.000

Income level3

     
 

1

1

 

1

 
 

2

1.00 (0.99–1.02)*

0.657

0.97 (0.96–0.99)

0.001

 

3

0.81 (0.80–0.82)

0.000

0.83 (0.82–0.85)

0.000

 

4

0.73 (0.71–0.74)

0.000

0.71 (0.70–0.72)

0.000

  1. IRR – incidence rate ratio, 95% – confidence interval, DDDs – defined daily doses
  2. 1Adjusted for multi-morbidity, 2Adjusted for multi-morbidity and gender, 3Adjusted for multimorbidity,
  3. gender and age.